ESR1 and breast carcinoma: Various mechanisms, including inhibition of cell proliferation, [6,11] apoptosis [11], cell cycle arrest, inhibition of metastasis [6], downregulation of estrogen receptor alpha (ER-α) expression [7], and inhibition of angiogenesis of cells, are involved in anticancer effects on breast cancer [3].